CIK 0000313143
- Large accelerated filer
HAEMONETICS CORP
Sign in to watch- Ticker
- HAE
- Exchange
- NYSE
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Apr 3
- Incorporated
- MA
- Entity type
- Operating
- EIN
- 042882273
- Phone
- +1 781-848-7100
- Business address
- 125 SUMMER STREET, BOSTON, MA, 02110
- 4 Open-market sale President & CEO sold 1,008 shares at $100.44 ($101,244)
- 4 Open-market sale VP, Corporate Controller sold 143 shares at an average $101.34 ($14,492)
- 4 Open-market sale SVP, Global Manufacturing sold 107 shares at $100.44 ($10,747)
- 4 Grant or award EVP, Chief Technology Officer acquired 1,209 shares (grant or award)
- 4 Open-market sale SVP, Global Human Resources sold 110 shares at $100.44 ($11,048)
- 4 Open-market sale EVP and General Counsel sold 203 shares at $100.44 ($20,389)
- 4 Open-market sale EVP, Chief Financial Officer sold 221 shares at $100.44 ($22,197)
- 4 Grant or award Director acquired 478 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Grant or award EVP, Chief Technology Officer acquired 2,181 shares (grant or award)
- 4 Open-market sale Director sold 10,902 shares at $102.00 ($1,112,004)
- 4 Open-market sale VP, Corporate Controller sold 3,207 shares at an average $101.20 ($324,560)
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale EVP and General Counsel sold 395 shares at $98.00 ($38,710)
- 4 Open-market sale SVP, Global Human Resources sold 1,624 shares at an average $100.21 ($162,737)
- 4 Open-market sale EVP, Chief Technology Officer sold 339 shares at $118.27 ($40,094)
- 4 Open-market sale Director sold 16,926 shares at $118.26 ($2,001,669)
- 4 Open-market sale Director sold 6,573 shares at $118.15 ($776,600)
- 4 Open-market sale VP, Corporate Controller sold 1,793 shares at an average $120.63 ($216,296)
- 4 Open-market sale EVP, Chief Financial Officer sold 13,834 shares at an average $120.45 ($1,666,271)
Page 14 of 60 · 1,191 filings